Business Context and Reporting Period
Company: Focus Universal Inc. (FCUV)
Filing Type: Form 8-K (Current Report)
Date of Report: October 20, 2025 (Events reported through October 27, 2025)
Principal Executive Offices: Ontario, California
Business Context: The Company announced the closing of a $10,000,000 preferred equity private placement. This filing details the entry into material definitive agreements for Series A and Series B Convertible Preferred Stock and the corresponding amendments to the Articles of Incorporation.
Key Financial Metrics and Capital Structure
Capital Raised: Total commitment of $10,000,000 in preferred equity.
- Series A Preferred Stock: $3,000,000 aggregate purchase price for 750,000 shares at $4.00 per share. Lead investor is Edward Lee, Chairman of the Board.
- Series B Preferred Stock: Up to $7,000,000 commitment for 8,236 shares at $850.00 per share (15% original issuance discount).
Liquidity and Debt: The filing does not provide specific data on current cash balances, operating cash flow, or existing debt levels. The primary financial impact is the influx of capital from the private placements.
Profit and Margins: The filing does not contain revenue, profit, or margin data.
Material Changes and Transaction Details
Series A Private Placement:
- Closing: Committed on or about October 20, 2025; Subscription agreements dated October 15, 2025.
- Investors: Edward Lee (Chairman) and other accredited investors.
- Terms: Convertible into 1.1 shares of Common Stock per share. Ranks senior to Common Stock in liquidation. No redemption rights.
Series B Private Placement:
- Agreement Date: October 21, 2025.
- Structure: Three closings: (i) $3,000,000 initial; (ii) $1,000,000 upon filing of Form S-1 and Information Statement; (iii) $3,000,000 within two business days of SEC effectiveness.
- Conversion: Voluntary conversion at 85% of the lowest 10-day VWAP. Triggering Event conversion at the lesser of the Conversion Price or 75% of the lowest 10-day VWAP.
- Anti-Dilution: Includes conversion price protection if securities are issued at a lower price.
- Participation: Holders have the right to participate in 30% of any subsequent exempt financing for six months.
Corporate Governance Changes:
- Lock-Up: Executive officers and 5% shareholders are locked up from October 21, 2025, to December 29, 2025.
- Registration Rights: Entered into a Registration Rights Agreement for Series B investors.
- Placement Agent: Spartan Capital Securities, LLC appointed as placement agent.
Guidance, Risks, and Contingencies
Management Commentary: The filing focuses on the execution of the capital raise and the legal terms of the preferred stock designations. No forward-looking financial guidance or operational outlook is provided in this document.
Risks and Contingencies:
- Regulatory Approval: The final $3,000,000 tranche of the Series B placement is contingent upon the SEC declaring the Registration Statement effective.
- Dilution: Series B holders have significant anti-dilution protections and participation rights in future financings, which may impact existing common shareholders.
- Conversion Limits: Beneficial ownership limitation caps conversion at 4.99% of outstanding Common Stock to prevent excessive dilution by a single holder.
Investor Verification Checklist
- Capital Utilization: Verify how the $10,000,000 raised will be deployed (e.g., operations, debt repayment, acquisitions) as this is not detailed in the 8-K.
- Series B Closing Conditions: Monitor the status of the Form S-1 filing and SEC effectiveness to confirm the release of the remaining $4,000,000 Series B commitment.
- Common Stock Impact: Assess the potential dilution from the Series A conversion ratio (1.1:1) and the Series B floating conversion price (85% of VWAP).
- Lock-Up Expiration: Note the December 29, 2025, expiration of the lock-up agreement for insiders and major shareholders.
- Financial Health: Review the most recent 10-K or 10-Q to understand the Company's current liquidity position prior to this capital injection.